Zink W, Graf B M
Klinik für Anaesthesiologie, Universitätsklinikum Heidelberg.
Anaesthesist. 2003 Dec;52(12):1102-23. doi: 10.1007/s00101-003-0617-5.
Regardless of their specific physico-chemical properties and chemical structures, all local anaesthetic agents block neuronal voltage-gated sodium channels, and thus suppress conduction in peripheral nerves. Since these ion channels ubiquitously appear in excitable membranes, systemic accumulation of local anaesthetic agents may affect the functional integrity of these structures. Clinically, local anaesthetic-induced systemic toxicity results in central nervous and cardiovascular malfunction. With regard to CNS toxicity, symptoms which are largely drug-independent appear in a characteristic biphasic sequence. Nevertheless, the plasma levels necessary to provoke these symptoms are to a large extent agent-specific. Initially, these toxic mechanisms are due to a selective blockade of cortical inhibitory neurons, which enables the formation of seizure potentials within subcortical structures. With high cerebral drug levels, however, excitatory neurons are also increasingly blocked, resulting in coma, apnoeic episodes and circulatory failure. Direct cardiac effects of local anaesthetics can be divided into (i) stereospecific inhibition of intracardial conduction and (ii) unspecific inhibition of myocardial energy supply and ion channels. The corresponding spectrum of symptoms is not uniform and may range from extreme bradycardia, (malignant) ventricular arrhythmia to refractory cardiac arrest. Local tissue toxicity has to be strictly delimited from systemic toxicity and allergies, respectively, which are mainly caused by aminoester agents. Local anaesthetics may cause neuronal and striated muscle injury at the site of injection. With regard to (central) neurotoxicity, "transient neurologic symptoms" and "cauda equina syndrome" have been increasingly recognised. However, the clinical relevance of local anaesthetic-induced myotoxicity is still controversly discussed. In order to avoid systemic accumulation of local anaesthetic agents, several safety procedures have to be considered during the application of these drugs. The treatment of systemic toxicity is strictly dependent on the expression of symptoms. However, hypoxia and acidotic episodes must be avoided and must be treated aggressively.
所有局部麻醉药,无论其具体的物理化学性质和化学结构如何,均会阻断神经元电压门控钠通道,从而抑制周围神经的传导。由于这些离子通道普遍存在于可兴奋膜中,局部麻醉药的全身蓄积可能会影响这些结构的功能完整性。临床上,局部麻醉药引起的全身毒性会导致中枢神经和心血管功能障碍。关于中枢神经系统毒性,很大程度上与药物无关的症状会以特征性的双相顺序出现。然而,引发这些症状所需的血浆水平在很大程度上因药物而异。最初,这些毒性机制是由于皮质抑制性神经元的选择性阻断,这使得皮质下结构内能够形成癫痫电位。然而,当脑内药物水平较高时,兴奋性神经元也会越来越多地被阻断,从而导致昏迷、呼吸暂停发作和循环衰竭。局部麻醉药对心脏的直接作用可分为:(i)对心内传导的立体特异性抑制和(ii)对心肌能量供应和离子通道的非特异性抑制。相应的症状谱并不一致,可能从极度心动过缓、(恶性)室性心律失常到难治性心脏骤停。局部组织毒性必须分别与主要由氨基酯类药物引起的全身毒性和过敏严格区分开来。局部麻醉药可能会在注射部位导致神经元和横纹肌损伤。关于(中枢)神经毒性,“短暂性神经症状”和“马尾综合征”越来越受到认可。然而,局部麻醉药引起的肌毒性的临床相关性仍存在争议。为避免局部麻醉药的全身蓄积,在应用这些药物时必须考虑几种安全措施。全身毒性的治疗严格取决于症状的表现。然而,必须避免并积极治疗缺氧和酸中毒发作。